Novel, experimental treatment for emphysema may offer promising results for patients looking to breathe easier ...
GSK plc GSK announced that the European Commission has approved its blockbuster respiratory drug, Nucala (mepolizumab), for ...
GSK (GSK) on Friday announced that the European Commission has approved its Nucala asthma therapy for patients with chronic ...
GSK announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults in the EU with uncontrolled COPD characterised by raised blood eosinophils ...